Lactose (India) Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹67
- Today's High:
- ₹71
- Open Price:
- ₹70.49
- 52W Low:
- ₹39.25
- 52W High:
- ₹80.14
- Prev. Close:
- ₹69
- Volume:
- 8997
Company Statistics
- Market Cap.:
- ₹178.31 million
- Book Value:
- 31.589
- Revenue TTM:
- ₹346.23 million
- Operating Margin TTM:
- 4.58%
- Gross Profit TTM:
- ₹325.60 million
- Profit Margin:
- -6.73%
- Return on Assets TTM:
- 1.2%
- Return on Equity TTM:
- -7.01%
Company Profile
Lactose (India) Limited had its IPO on under the ticker symbol 524202.
The company operates in the Healthcare sector and Drugs - Generic industry. Lactose (India) Limited has a staff strength of 112 employees.
Stock update
Shares of Lactose (India) Limited opened at ₹70.49 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹67 - ₹71, and closed at ₹67.54.
This is a -2.12% slip from the previous day's closing price.
A total volume of 8,997 shares were traded at the close of the day’s session.
In the last one week, shares of Lactose (India) Limited have slipped by -4.43%.
Lactose (India) Limited's Key Ratios
Lactose (India) Limited has a market cap of ₹178.31 million, indicating a price to book ratio of 0.7266 and a price to sales ratio of 0.6952.
In the last 12-months Lactose (India) Limited’s revenue was ₹346.23 million with a gross profit of ₹325.60 million and an EBITDA of ₹55.84 million. The EBITDA ratio measures Lactose (India) Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Lactose (India) Limited’s operating margin was 4.58% while its return on assets stood at 1.2% with a return of equity of -7.01%.
In Q3, Lactose (India) Limited’s quarterly earnings growth was a negative -70.6% while revenue growth was a negative 19.4%.
Lactose (India) Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 344.2857
- PEG
Its diluted EPS in the last 12-months stands at ₹-2.266 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lactose (India) Limited’s profitability.
Lactose (India) Limited stock is trading at a EV to sales ratio of 1.8225 and a EV to EBITDA ratio of 10.32. Its price to sales ratio in the trailing 12-months stood at 0.6952.
Lactose (India) Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.02 billion
- Total Liabilities
- ₹265.67 million
- Operating Cash Flow
- ₹-10184000.00
- Capital Expenditure
- ₹15.61 million
- Dividend Payout Ratio
- 0%
Lactose (India) Limited ended 2024 with ₹1.02 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.02 billion while shareholder equity stood at ₹405.61 million.
Lactose (India) Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹265.67 million in other current liabilities, 125890000.00 in common stock, ₹279.72 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹5.81 million and cash and short-term investments were ₹10.16 million. The company’s total short-term debt was ₹57,859,000 while long-term debt stood at ₹330.38 million.
Lactose (India) Limited’s total current assets stands at ₹375.00 million while long-term investments were ₹0 and short-term investments were ₹1.01 million. Its net receivables were ₹124.92 million compared to accounts payable of ₹0 and inventory worth ₹227.80 million.
In 2024, Lactose (India) Limited's operating cash flow was ₹-10184000.00 while its capital expenditure stood at ₹15.61 million.
Comparatively, Lactose (India) Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹67.54
- 52-Week High
- ₹80.14
- 52-Week Low
- ₹39.25
- Analyst Target Price
- ₹
Lactose (India) Limited stock is currently trading at ₹67.54 per share. It touched a 52-week high of ₹80.14 and a 52-week low of ₹80.14. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹62.89 and 200-day moving average was ₹52.25 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5041.8% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Lactose (India) Limited
Similar Industry Stocks (Drugs - Generic)
Most Active
Top Gainers
Top Losers
About
Lactose (India) Limited manufactures and trades in pharmaceutical products in India. The company offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in liquid dose forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic; and galacto-oligosaccharides, a prebiotic for use in dairy and bakery products, beverages, infant and clinical nutrition, and geriatric nutrition applications, as well as in products for children or adolescents. The company also exports its products to Russia, Kazakhstan, Belarus, Nigeria, Sri Lanka, and other countries. Lactose (India) Limited was founded in 1991 and is headquartered in Mumbai, India.